scholarly journals Evaluating the Usability of mHealth Applications on Type 2 Diabetes Mellitus Using Various MCDM Models

Healthcare ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 4
Author(s):  
Kamaldeep ◽  
Sharmistha Roy ◽  
Ramesh Chandra Poonia ◽  
Soumya Ranjan Nayak ◽  
Raghvendra Kumar ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Customer Satisfaction ◽  
Research Work ◽  
Promethee Ii ◽  
Attribute Weights ◽  
Recent Developments ◽  
User Friendly

The recent developments in the IT world have brought several changes in the medical industry. This research work focuses on few mHealth applications that work on the management of type 2 diabetes mellitus (T2DM) by the patients on their own. Looking into the present doctor-to-patient ratio in our country (1:1700 as per a Times of India report in 2021), it is very essential to develop self-management mHealth applications. Thus, there is a need to ensure simple and user-friendly mHealth applications to improve customer satisfaction. The goal of this study is to assess and appraise the usability and effectiveness of existing T2DM-focused mHealth applications. TOPSIS, VIKOR, and PROMETHEE II are three multi-criteria decision-making (MCDM) approaches considered in the proposed work for the evaluation of the usability of five existing T2DM mHealth applications, which include Glucose Buddy, mySugr, Diabetes: M, Blood Glucose Tracker, and OneTouch Reveal. The methodology used in the research work is a questionnaire-based evaluation that focuses on certain attributes and sub-attributes, identified based on the features of mHealth applications. CRITIC methodology is used for obtaining the attribute weights, which give the priority of the attributes. The resulting analysis signifies our proposed research by ranking the mHealth applications based on usability and customer satisfaction.

scholarly journals Gaussian Model to Predict the Risk of Developing Type 2 Diabetes Mellitus in Mexican Population Taking as a Reference Risk Factors

2020 ◽  
Vol 9 (3) ◽  
pp. 42
Author(s):  
Guerrero-Escamilla Juan Bacilio ◽  
Lopez-Perez Socrates ◽  
Jiménez-Proa Erik Gerardo
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Adult Population ◽  
Research Work ◽  
Gaussian Model ◽  
Mexican Population ◽  
Nutrition Survey

In this research work, an ordinal Gaussian model is constructed, whose objective is to predict the degree of risk of contracting type 2 diabetes mellitus (2DM), taking as reference the risk factors in the Mexican population. It is estimated that the Mexican population has a hereditary susceptibility to develop 2DM, however, the probability increases depending on risk factors; area of residence, background of parents with 2DM, tobacco consumption, alcohol consumption, physical inactivity, body mass index (BMI), and type of feeding, which, despite positively intervening in the appearance of 2DM, they can be modified to obtain the inversely proportional effect. However, the social, economic and political context are important components for the population. Risk factors, as explanatory elements of the prevalence of 2DM, are of the utmost importance to delay or control their early development, as some are factors that can be muffled. For the development of this model, the information published in the National Health and Nutrition Survey (ENSANUT) of 2012 was taken, based on the adult population 20 years of age or older. Among the most outstanding results is the higher prevalence of risk that women have with respect to men, and the fact that age is a fundamental basis for contracting type 2 diabetes mellitus.

scholarly journals MEAN SERUM FERRITIN LEVELS IN TYPE-2 DIABETES MELLITUS IN PAKISTANI POPULATION

2021 ◽  
Vol 71 (Suppl-1) ◽  
pp. S15-18
Author(s):  
Kamran Ali ◽  
Qasim Raza ◽  
Tarique Ahmed Maka
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Serum Ferritin ◽  
Research Work ◽  
Military Hospital ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Cross Sectional

Objective: To evaluate the mean serum ferritin in type-2 diabetic patients. Study Design: Cross-sectional study. Place and Duration of Study: Department of Medicine, Combined Military Hospital, Peshawar, from Sep 2014 to Feb 2015. Methodology: A total of one hundred patients with type-2 diabetes mellitus fulfilling inclusion criteria were selected. Blood sample was collected from all patients by the clean-catch technique after they received standardized verbal instructions. Blood samples were seen by classified pathologist in the laboratory. Results: Mean age of patients was 55.51 ± 5.40 years with 60% male gender predominating the overall sample of diabetics. Mean serum ferritin was 219 ± 70.67 ng/ml and mean HbA1c was 7.24 ± 0.61%. Stratification with regard to age and gender was also carried out. Conclusion: Serum ferritin levels were observed raised in type-2 diabetics, suggestive of possible role in the pathogenesis of type-2 diabetes mellitus. We recommend further research work over its pathogenesis so that the guidelines for its control may be formulated.

Recent Developments in Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors as a Valuable Tool in the Treatment of Type 2 Diabetes Mellitus

2020 ◽  
Vol 20 (3) ◽  
pp. 170-182
Author(s):  
Shubham Kumar ◽  
Gopal L. Khatik ◽  
Amit Mittal
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Oral Antidiabetic Agents ◽  
Oral Antidiabetic ◽  
Glucose Reabsorption ◽  
Pathogenic Factors ◽  
Recent Developments ◽  
Diabetes Progression

In today’s world, metabolic disorders are much dominant, and among them, diabetes is causing the highest rate of mortality. There is no cure for diabetes, while treatment could be done either by insulin therapy or oral antidiabetic drug. Oral antidiabetic agents target pathogenic factors like receptors, enzymes, genes and proteins involved in diabetes progression. Among them, recently, sodium-glucose co-transporters (SGLTs) have been recognized for their potential to effectively treat Type 2 diabetes mellitus. SGLTs are classified as SGLT-1 and SGLT-2, and among them, SGLT-2 is a major transporter which is involved in glucose reabsorption. Therefore, targeting SGLTs by its inhibitors could be a better choice to control the blood glucose level. Canagliflozin, dapagliflozin, empagliflozin, ipragliflozin, luseogliflozin, and tofogliflozin are known to be SGLT-2 inhibitors. Herein, we discussed the current and future aspects of the development and applications of SGLT-2 inhibitors.

scholarly journals Didymocarpus Pedicellate: Bioactive Constituent, Their Molecular Target in Diabetes Mellitus

2021 ◽  
Vol 70 (1) ◽  
Author(s):  
Yogeshwary M. Bhongade ◽  
Maheshwari M. Bhongade ◽  
Shubham N. Gharat
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Antimalarial Activity ◽  
Chemical Constituents ◽  
Research Work ◽  
Cardiovascular Complications ◽  
Bioactive Constituents ◽  
Tissue Sensitivity

Didymocarpus pedicellata (Family: Gesneriaceae), is an herbal drug traditionally used in renal disorders mainly as antiurolithiatic and do not have much data on this plant, is selected for study and hereby reviewed. This review is based on compilation of data from the various researchers on their research work and other data including anti-diabetic activity of Didymocarpus pedicellata and antioxidant activity in relation with the type 2 diabetes mellitus and its cardiovascular complications. By using various scientific studies, the evidence has been demonstrated as to the antidiabetic effect of the various extract of Didymocarpus pedicellata as well as its chemical constituents including various flavonoid like chalcones which are major bioactive constituents chiefly present in Didymocarpus pedicellata. The chalcones present in these plants have various therapeutic targets for the management of type 2 diabetes like PPARg, DPP-4, a-glucosidase, PTP1B, aldose reductase, and stimulate insulin secretion and tissue sensitivity. The Didymocarpus pedicellata has also been reported to exhibit antispasmolytic, antimalarial activity and nephroprotective activity. On the basis of given evidence, it may be concluded that Didymocarpus pedicellata could be the potential target for the treatment of type 2 diabetes mellitus and can reduce the cardiovascular complication associated with diabetes mellitus.

Sign in / Sign up

Export Citation Format

Share Document